New trends in anaphylaxis

Margitta Worm1, Gunter J. Sturm2, Jörg Kleine‐Tebbe3, Ewa Cichocka‐Jarosz4, Victòria Cardona5, Ioana Maris6, Sabine Dölle1
1Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany
2University Department of Dermatology and Venereology, Medical University Graz, Graz, Austria
3Hanf, Ackermann and Kleine-Tebbe Allergy Practice, Allergy and Asthma Center Westend, Berlin, Germany
4Department of Pediatrics, Pulmonology, Allergology, and Dermatology Division, Institute of Pediatrics, Jagiellonian University Medical College, Krakau, Poland
5Allergy Section, Department of Internal Medicine, University Hospital Vall d’Hebron, Barcelona, Spain
6Department of Paediatrics and ChildHealth, University College Cork, Cork, Ireland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69:1397–404.

Worm M, Eckermann O, Dölle S, Aberer W, Beyer K, Hawranek T, et al. Auslöser und Therapie der Anaphylaxie. Dtsch Arztebl Int. 2014;111:367–75.

Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137:1128–1137.e1.

Goldberg A, Confino-Cohen R. Bee venom immunotherapy—how early is it effective? Allergy. 2010;65:391–5.

Dhami S, Zaman H, Varga EM, Sturm GJ, Muraro A, Akdis CA, et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy. 2017;72:342–65.

Sturm G, Kränke B, Rudolph C, Aberer W. Rush hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol. 2002;110:928–33.

Roumana A, Pitsios C, Vartholomaios S, Kompoti E, Kontou-Fili K. The safety of initiating hymenoptera immunotherapy at 1 microg of venom extract. J Allergy Clin Immunol. 2009;124:379–81.

Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al. European academy of allergy and clinical immunology interest group. Predictors of side effects during the buildup phase of venom immunotherapy for hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol. 2010;126:105–111.e5.

Stoevesandt J, Hain J, Stolze I, Kerstan A, Trautmann A. Angiotensin-converting enzyme inhibitors do not impair the safety of hymenoptera venom immunotherapy build-up phase. Clin Exp Allergy. 2014;44:747–55.

Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serum tryptase—a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047–54.

Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and underestimated parameters in severe hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. J Allergy Clin Immunol. 2012;130:698–704.e1.

Pitsios C, Demoly P, Bilò MB, Gerth van Wijk R, Pfaar O, Sturm GJ, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015;70:897–909.

Nassiri M, Eckermann O, Babina M, Edenharter G, Worm M. Serum levels of 9α,11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. J Allergy Clin Immunol. 2016;137:312–4.

Jakob T, Rafei-Shamsabadi D, Spillner E, Müller S. Diagnostics in hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics. Allergo J Int. 2017;26:93–105.

Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, et al. EAACI molecular allergology user’s guide. Pediatr Allergy Immunol. 2016;27(Suppl 23):1–250.

Frick M, Fischer J, Helbling A, Ruëff F, Wieczorek D, Ollert M, et al. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. J Allergy Clin Immunol. 2016;138:1663–1671.e9.

Bilò MB, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink JN, Lange J, Jakob T, et al. Self-medication of anaphylactic reactions due to hymenoptera stings—an EAACI Task Force Consensus Statement. Allergy. 2016;71:931–43.

Song TT, Worm M, Lieberman P. Anaphylaxis treatment: current barriers to adrenaline auto-injector use. Allergy. 2014;69:983–91.

Ridolo E, Montagni M, Bonzano L, Savi E, Peveri S, Costantino MT, et al. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients. Intern Emerg Med. 2015;10:937–41.

Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J. Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department. Allergy. 2017;72:492–7.

EAACI Food Allergy and Anaphylaxis Guidelines Group, Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69:1008–25.

Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J, et al. Leitlinie zu Akuttherapie und Management der Anaphylaxie: S2-Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbands Deutscher Allergologen (AeDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Deutschen Akademie für Allergologie und Umweltmedizin (DAAU), des Berufsverbands der Kinder- und Jugendärzte Deutschlands (BVKJ), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI), der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI), der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI), der Deutschen Gesellschaft für Pharmakologie (DGP), der Deutschen Gesellschaft für Psychosomatische Medizin (DGPM), der Arbeitsgemeinschaft Anaphylaxie Training und Edukation (AGATE) und der Patientenorganisation Deutscher Allergie- und Asthmabund (DAAB). Allergo J Int. 2014;23:96–112.

Wedi B, Ruëff F. Pharmacoprophylaxis and co-medications in allergen-specific immunotherapy. Hautarzt. 2011;62:663–70.

Needham JM, Nicholas SK, Davis CM. Food allergies developing after solid organ transplant. Pediatr Transplant. 2015;19:827–35.

Dewachter P, Vézinet C, Nicaise-Roland P, Chollet-Martin S, Eyraud D, Creusvaux H, et al. Passive transient transfer of peanut allergy by liver transplantation. Am J Transplant. 2011;11:1531–4.

Chalabianloo F, Berstad A, Schjøtt J, Riedel B, Irgens A, Florvaag E. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study. Pharmacoepidemiol Drug Saf. 2011;20:506–13.

Luengo O, Cardona V. Component resolved diagnosis: when should it be used? Clin Transl Allergy. 2014;4:28.

Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009;124:652–7.

O’Neil BH, Allen R, Spigel DR, Stinchcombe TE, Moore DT, Berlin JD, et al. High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history. J Clin Oncol. 2007;25:3644–8.

Heaps A, Carter S, Selwood C, Moody M, Unsworth J, Deacock S, et al. The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis. Clin Exp Immunol. 2014;177:483–90.

Anaphylaxis Working Group of the French Allergology Society, Pouessel G, Galand J, Beaudouin E, Renaudin JM, Labreuche J, Moneret-Vautrin DA, et al. The gaps in anaphylaxis diagnosis and management by French physicians. Pediatr Allergy Immunol. 2017;28:295–8.

Jongco AM, Bina S, Sporter RJ, Cavuoto Petrizzo MA, Kaplan B, Kline M, et al. A simple allergist-led intervention improves resident training in anaphylaxis. J Allergy (Cairo). 2016; https://doi.org/10.1155/2016/9040319 .

Mileder LP, Kopaunik LS, Alberer M, Wetzel J, Karnberger A, Kneihsl M, et al. Simulation-based training and its effect on management of severe anaphylaxis—Are 4 Hs enough? Resuscitation. 2016;98:e12–e3.

Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Classen M, et al. Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (Æ-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF). Allergo J Int. 2015;24:256–93.